MENU
+Compare
IRMD
Stock ticker: NASDAQ
AS OF
Nov 26, 02:36 PM (EDT)
Price
$92.09
Change
-$0.13 (-0.14%)
Capitalization
1.17B

IRMD iRadimed Corp Forecast, Technical & Fundamental Analysis

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them... Show more

IRMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for IRMD with price predictions
Nov 25, 2025

IRMD's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for IRMD turned positive on November 20, 2025. Looking at past instances where IRMD's MACD turned positive, the stock continued to rise in of 59 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 19, 2025. You may want to consider a long position or call options on IRMD as a result. In of 120 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IRMD advanced for three days, in of 259 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 230 cases where IRMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IRMD broke above its upper Bollinger Band on November 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IRMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.933) is normal, around the industry mean (63.344). P/E Ratio (55.897) is within average values for comparable stocks, (36.790). IRMD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.720). IRMD has a moderately low Dividend Yield (0.007) as compared to the industry average of (0.019). P/S Ratio (14.706) is also within normal values, averaging (85.888).

View a ticker or compare two or three
IRMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

IRMD is expected to report earnings to fall 1.06% to 46 cents per share on January 29

iRadimed Corp IRMD Stock Earnings Reports
Q4'25
Est.
$0.47
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.05
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.03
The last earnings report on November 03 showed earnings per share of 46 cents, beating the estimate of 46 cents. With 26.27K shares outstanding, the current market capitalization sits at 1.17B.
A.I.Advisor
published Dividends

IRMD paid dividends on November 25, 2025

iRadimed Corp IRMD Stock Dividends
А dividend of $0.17 per share was paid with a record date of November 25, 2025, and an ex-dividend date of November 14, 2025. Read more...
A.I. Advisor
published General Information

General Information

a provider of non-magnetic intravenous infusion pump systems

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1025 Willa Springs Drive
Phone
+1 407 677-8022
Employees
148
Web
https://www.iradimed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UBVTX79.751.46
+1.86%
Undiscovered Managers Behavioral Val R3
MNDHX27.880.50
+1.83%
MFS New Discovery R3
GGEAX25.790.23
+0.90%
Nationwide Schroders Global Eq A
GRZZX21.02N/A
N/A
Leuthold Grizzly Short Fund
LLSCX28.86N/A
N/A
Longleaf Partners Small-Cap

IRMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with HBIO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then HBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
+2.13%
HBIO - IRMD
45%
Loosely correlated
+15.21%
BIO - IRMD
44%
Loosely correlated
+3.02%
TWST - IRMD
41%
Loosely correlated
+6.07%
ICUI - IRMD
40%
Loosely correlated
+2.30%
ATEC - IRMD
39%
Loosely correlated
+5.82%
More

Groups containing IRMD

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
+2.13%
Medical/Nursing Services
industry (216 stocks)
45%
Loosely correlated
+0.37%
Health Services
industry (423 stocks)
3%
Poorly correlated
+0.28%